Daptomycin Production Cost Reports

The report provides a detailed analysis essential for establishing a Daptomycin production plant. It encompasses all critical aspects necessary for Daptomycin production, including the cost of Daptomycin production, Daptomycin plant cost, Daptomycin production costs, and the overall Daptomycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Daptomycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Daptomycin is a potent cyclic lipopeptide antibiotic extensively used in the pharmaceutical and medical industries for treating complicated skin and soft tissue infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and other resistant Gram-positive strains.

It is also indicated for bloodstream infections (bacteraemia), right-sided endocarditis due to Staphylococcus aureus, and other severe systemic infections. Its mode of action involves disrupting bacterial cell membrane integrity and biosynthesis, leading to bacterial cell death.

The market demand for Daptomycin is driven by the rising prevalence of antibiotic-resistant Gram-positive bacterial infections such as MRSA and vancomycin-resistant Enterococci, which increase the demand for effective antibiotic treatments. The growing incidence of complicated skin infections, bacteraemia, and right-sided infective endocarditis also significantly drives market growth. Advances in healthcare infrastructure, especially in North America and emerging economies in the Asia-Pacific region and increasing hospital-associated infections elevate the need for potent antibiotics like Daptomycin.

dditionally, expanding indications for daptomycin use, ongoing research and development for novel formulations, and the increasing adoption in hospital and acute-care settings further propel the market. The market is also led by major pharmaceutical companies investing in improving drug access, delivery, and antimicrobial stewardship programs. However, factors such as high treatment costs, regulatory hurdles, and generic competition affect industrial daptomycin procurement.

Raw Material for Daptomycin Production

According to the Daptomycin production plant project report, the various raw materials for Daptomycin production include Fmoc-protected amino acids.

Production Process of Daptomycin

The extensive Daptomycin production cost report consists of the following major industrial production process:

1. Production via solid-phase peptide synthesis: The production process of Daptomycin primarily involves solid-phase peptide synthesis (SPPS) complemented by solution-phase steps to overcome key synthetic challenges. The synthesis begins with assembling the peptide chain on a solid resin, using Fmoc-protected amino acids and strategic building blocks. A critical aspect is the preparation of the kynurenine (Kyn) residue through ozonolysis of an N-Boc-protected tryptophan derivative, enabling large-scale, practical incorporation of this nonproteinogenic amino acid. Macrocyclization to form the 31-membered cyclic depsipeptide ring is efficiently achieved by chemoselective serine ligation. Finally, an esterification reaction using DIC/DMAP is employed to form ester linkages essential for Daptomycin’s structure.

Properties of Daptomycin

Daptomycin is a cyclic lipopeptide antibiotic with a molecular formula of C72H101N17O26 and a molecular weight of 1620.7 Da. It is a solid, cyclic depsipeptide comprising 13 amino acids, including several non-standard and D-amino acids, with an ester-linked ring formed by 10 C-terminal amino acids, and a decanoic acid linked to the N-terminal tryptophan residue. It is an anionic molecule that requires calcium ions (Ca2+) for its antibacterial activity, enabling it to bind bacterial membranes. It exhibits low water solubility (~0.0173 mg/mL) and a negative logP indicative of hydrophilicity. It contains 22 hydrogen bond donors, 27 acceptors, has a polar surface area of 702 Ų, and 35 rotatable bonds, reflecting a flexible and polar structure.